Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak 2020-02-12 08:00
111 Partners with Winhealth to Offer "Free Refill + End-to-End Delivery" Services to Patients with Chronic Diseases 2020-02-12 06:00
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries 2020-02-11 08:51
Yuyu's First Generic Newmacor's 5-year Cumulative Sales Surpasses 40 Million Capsules 2020-02-10 22:00
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours 2020-02-06 22:46
Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases 2020-02-05 13:21
Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020 2020-02-04 13:50
China Jo-Jo Drugstores Steps in to Help Combat the 2019 Novel Coronavirus 2020-02-04 06:00
CStone successfully hosted the first U.S. R&D Day in New York 2020-01-24 08:03
TenNor Therapeutics Received FDA Orphan Drug Designation 2020-01-20 20:50
Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC 2020-01-20 10:44
111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference 2020-01-17 20:00
China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory 2020-01-16 21:00
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany 2020-01-16 10:39
Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline" 2020-01-16 07:30
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases 2020-01-09 17:10
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies 2020-01-07 22:00
GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR 2020-01-06 14:39
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency 2020-01-03 23:30
Bridge Biotherapeutics Announces China NMPA Clearance of IND for BBT-401, a Pellino-1 Inhibitor for UC 2019-12-27 06:30
1 123 124 125 126 127 165